Imricor Medical Systems, Inc. (IMR.AX)
AUD 0.96
(-2.05%)
AUD 0.96
(-2.05%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 25 Million AUD | 303.92% |
| 2022 | 6.19 Million USD | 38.68% |
| 2021 | 4.46 Million AUD | -6.09% |
| 2020 | 4.75 Million AUD | 36.27% |
| 2019 | 3.48 Million AUD | 34.78% |
| 2018 | 2.58 Million AUD | -68.63% |
| 2017 | 8.25 Million AUD | 10.08% |
| 2016 | 7.49 Million AUD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q2 | 14.14 Million USD | 0.0% |
| 2024 Q1 | 14.14 Million USD | -17.12% |
| 2023 Q1 | 8.98 Million USD | 45.19% |
| 2023 FY | 25 Million AUD | 303.92% |
| 2023 Q3 | 17.06 Million USD | 89.83% |
| 2023 Q2 | 8.98 Million USD | 0.0% |
| 2023 Q4 | 17.06 Million USD | 0.0% |
| 2022 Q4 | 6.19 Million USD | 0.0% |
| 2022 FY | 6.19 Million USD | 38.68% |
| 2022 Q3 | 6.19 Million USD | 44.73% |
| 2022 Q1 | 4.27 Million USD | -4.18% |
| 2022 Q2 | 4.27 Million USD | 0.0% |
| 2021 Q3 | 4.46 Million USD | -3.92% |
| 2021 FY | 4.46 Million AUD | -6.09% |
| 2021 Q1 | 4.64 Million USD | -24.72% |
| 2021 Q4 | 4.46 Million AUD | 0.0% |
| 2021 Q2 | 4.64 Million USD | 0.0% |
| 2020 Q4 | 6.17 Million AUD | 29.84% |
| 2020 FY | 4.75 Million AUD | 36.27% |
| 2020 Q1 | 4.45 Million USD | 27.82% |
| 2020 Q2 | 4.45 Million USD | 0.0% |
| 2020 Q3 | 4.75 Million USD | 6.61% |
| 2019 Q4 | 3.48 Million USD | 0.0% |
| 2019 FY | 3.48 Million AUD | 34.78% |
| 2019 Q3 | 3.48 Million USD | -79.9% |
| 2019 Q2 | 17.35 Million USD | 0.0% |
| 2019 Q1 | 17.35 Million USD | 56.02% |
| 2018 FY | 2.58 Million AUD | -68.63% |
| 2018 Q1 | - USD | 0.0% |
| 2018 Q3 | 11.12 Million USD | 0.0% |
| 2018 Q4 | 11.12 Million USD | 0.0% |
| 2017 FY | 8.25 Million AUD | 10.08% |
| 2016 FY | 7.49 Million AUD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| 4DMedical Limited | 49.08 Million AUD | 49.063% |
| Adherium Limited | 3.4 Million AUD | -633.962% |
| Aroa Biosurgery Limited | 14.77 Million AUD | -69.192% |
| Atomo Diagnostics Limited | 1.29 Million AUD | -1831.74% |
| Anteris Technologies Ltd | 17.03 Million AUD | -46.746% |
| Control Bionics Limited | 2.75 Million AUD | -806.084% |
| CardieX Limited | 8.56 Million AUD | -192.028% |
| Compumedics Limited | 22.14 Million AUD | -12.896% |
| Cochlear Limited | 904.6 Million AUD | 97.236% |
| CleanSpace Holdings Limited | 6.94 Million AUD | -259.789% |
| Cyclopharm Limited | 13.65 Million AUD | -83.119% |
| EMVision Medical Devices Ltd | 5.45 Million AUD | -358.319% |
| Nova Eye Medical Limited | 8.55 Million AUD | -192.38% |
| HeraMED Limited | 1.5 Million AUD | -1560.381% |
| ImpediMed Limited | 6.24 Million AUD | -300.518% |
| InhaleRx Limited | 911.41 Thousand AUD | -2643.466% |
| LBT Innovations Limited | 5.5 Million AUD | -353.963% |
| Micro-X Limited | 12.63 Million AUD | -97.913% |
| Neurotech International Limited | 314.69 Thousand AUD | -7845.468% |
| OncoSil Medical Limited | 1.98 Million AUD | -1161.573% |
| PolyNovo Limited | 37.04 Million AUD | 32.499% |
| Respiri Limited | 3.55 Million AUD | -603.559% |
| SomnoMed Limited | 24.78 Million AUD | -0.903% |
| Universal Biosensors, Inc. | 10.61 Million AUD | -135.611% |
| Uscom Limited | 2.07 Million AUD | -1105.855% |
| Visioneering Technologies, Inc. | 2.76 Million AUD | -803.691% |